D. Ardicli Et Al. , "Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic," 22nd International Annual Congress of the World-Muscle-Society (WMS) , vol.27, Saint-Lo, France, 2017
Ardicli, D. Et Al. 2017. Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic. 22nd International Annual Congress of the World-Muscle-Society (WMS) , (Saint-Lo, France).
Ardicli, D., Nowak, K., Haliloglu, G., Goullee, H., Davis, M., Talim, B., ... Laing, N.(2017). Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic . 22nd International Annual Congress of the World-Muscle-Society (WMS), Saint-Lo, France
Ardicli, DİDEM Et Al. "Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic," 22nd International Annual Congress of the World-Muscle-Society (WMS), Saint-Lo, France, 2017
Ardicli, DİDEM Et Al. "Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic." 22nd International Annual Congress of the World-Muscle-Society (WMS) , Saint-Lo, France, 2017
Ardicli, D. Et Al. (2017) . "Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic." 22nd International Annual Congress of the World-Muscle-Society (WMS) , Saint-Lo, France.
@conferencepaper{conferencepaper, author={DİDEM ARDIÇLI Et Al. }, title={Utility of a next-generation sequencing (NGS)-based neuromuscular disease gene panel in an investigation of 30 families with early-onset presentation from a tertiary pediatric neuromuscular clinic}, congress name={22nd International Annual Congress of the World-Muscle-Society (WMS)}, city={Saint-Lo}, country={France}, year={2017}}